UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

ERJ open research, 2018-04, Vol.4 (2), p.120-2017

2018

Volltextzugriff (PDF)

Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management

The Annals of thoracic surgery, 2019-04, Vol.107 (4), p.1053-1059

2019

Volltextzugriff (PDF)

Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study)

International journal of environmental research and public health, 2022-12, Vol.19 (23), p.16246

2022

Volltextzugriff (PDF)

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

The European respiratory journal, 2015-05, Vol.45 (5), p.1403-1414

2015

Volltextzugriff (PDF)

Thymic metastasis from lung carcinoma

Interactive cardiovascular and thoracic surgery, 2011-05, Vol.12 (5), p.848-849

2011

Volltextzugriff (PDF)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

BMC cancer, 2021-12, Vol.21 (1)

2021

Volltextzugriff (PDF)

Efficacy of extracranial stereotactic body radiation therapy

BMC cancer, 2021-02, Vol.21 (1)

2021

Volltextzugriff (PDF)

Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study

BMC cardiovascular disorders, 2019-09, Vol.19 (1), p.212-212, Article 212

2019

Volltextzugriff (PDF)

Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4304-4304

2020

Volltextzugriff (PDF)

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Frontiers in endocrinology (Lausanne), 2013, Vol.3, p.184

2013

Volltextzugriff (PDF)

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20633-e20633

2016

Volltextzugriff (PDF)

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Biotechnology research international, 2016, Vol.2016, p.1-7

2016

Volltextzugriff (PDF)

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Clinical medicine insights. Therapeutics, 2010-01, Vol.2, p.179

2010

Volltextzugriff (PDF)

Association between lung cancer somatic mutations and occupational exposure in never-smokers

The European respiratory journal, 2017-10, Vol.50 (4), p.1700716-1700716

2017

Volltextzugriff (PDF)

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20543-e20543

2017

Volltextzugriff (PDF)

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

The European respiratory journal, 2015-05, Vol.45 (5), p.1415-1425

2015

Volltextzugriff (PDF)

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2231-2231

2014

Volltextzugriff (PDF)

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Volltextzugriff (PDF)

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Volltextzugriff (PDF)

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7511-7511

2014

Volltextzugriff (PDF)

Adenocarcinoma of the Lung in down Syndrome: First Clinical Report

Tumori, 2013-07, Vol.99 (4), p.169-171

2013

Volltextzugriff (PDF)

Risk of Childhood Cancer and Adult Lung Cancer after Childhood Exposure to Passive Smoke: A Meta-Analysis

Environmental health perspectives, 2000-01, Vol.108 (1), p.73-82

2000

Volltextzugriff (PDF)

Serum p53 antibodies as early markers of lung cancer

Nature medicine, 1995-07, Vol.1 (7), p.701-702

1995

Volltextzugriff (PDF)

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS7111-TPS7111

2012

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBulletin Du Cancer

ThemaBiological And Medical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management

Sleep Traits, Night Shift Work and Lung Cancer Risk among Women: Results from a Population-Based Case-Control Study in France (The WELCA Study)

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

Thymic metastasis from lung carcinoma

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Efficacy of extracranial stereotactic body radiation therapy

Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study

Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Association between lung cancer somatic mutations and occupational exposure in never-smokers

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Adenocarcinoma of the Lung in down Syndrome: First Clinical Report

Risk of Childhood Cancer and Adult Lung Cancer after Childhood Exposure to Passive Smoke: A Meta-Analysis

Serum p53 antibodies as early markers of lung cancer

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Aktive Filter

Suchergebnisse filtern